Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients.
Journal: Frontiers in oncology
Published: July 29, 2024
Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study.
Journal: Journal for immunotherapy of cancer
Published: July 10, 2020
Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy.
Journal: Journal of gastrointestinal oncology
Published: April 02, 2016
Showing 1-3 of 3
Last Updated: 09/26/2026